Drawing for EMTEKO

USPTO serial 79140783

EMTEKO

Reviewed by CopyMark Law Group

Reg. 4693760Status 404
Filing date
Status date
Registration date
Mar 3, 2015
Examiner
FIORELLI, JOANNA ELISA-HOLGUI
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EMTEKO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, namely, pharmaceutical preparations for prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; sanitary products for medicine, namely, sanitary preparations for medical use; dietetic food and substances for medical use, namely, crackers and pasta, adapted for medical use, dietetic sugar substitutes for medical use; food for babies; food supplements for humans; medical plasters, materials for dressings, namely, gauze for dressings; material for dental fillings and dental impressions; disinfectants, namely, all-purpose disinfectants, disinfectants for hygienic purposes, disinfectants for hygiene purposes, disinfectants for sanitary purposes, disinfectants for contact lenses; preparations for destroying vermin; tobacco-free cigarettes for medical purposes; antibiotics; vaccines; wadding for medical use; sea water for medicinal bathing; mineral waters for medical use; thermal water, namely, water from hot springs for medicinal bathing; mustard plasters in the nature of medical plasters; mud for baths, namely, herbal mud packs for therapeutic purposes; medicinal mud for therapeutic purposes; cod liver oil; iodine for pharmaceutical use; wart pencils for removing warts; bunion pads; callus removing preparations for medical purposes, namely, products for calluses in the nature of callus creams, sprays, ointments, and gels; anti-rheumatism rings; candy for pharmaceutical use; adhesive plaster for medical purposes; ointments for pharmaceutical use in the nature of mercurial ointments for pharmaceutical use, antibiotic ointments, anti-inflammatory ointments, hemorrhoidal ointments, medicated ointments for treating dermatological conditions, anti-itch ointments, medicated sunburn ointments, mentholated ointment for medical use; frostbite salve for pharmaceutical use; gauze for dressings; anti-horsefly oils in the nature of insect repellants; medicinal oils; medical dressings; medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medicines for dental use; filled first-aid boxes; medicinal drinks; malted milk beverages for medical use; narcotics in the nature of prescription synthetic narcotics; antiseptic preparations in the nature of tinctures for medical purposes, namely, tinctures of iodine, mercurial and alcohol tinctures for medical use; sanitary panties; absorbent underpants for incontinence; sanitary napkins for incontinence; hydrogen peroxide for medical purposes; plasters, namely, medical plasters, corn plasters, court plasters; eyepatches for medical purposes; compresses, namely, eye compresses, medicated compresses; surgical dressings; breast-nursing pads; medicated hair care preparations in the nature of pomades for medical use; belts for sanitary towels; sanitary tampons; bacterial preparations for medical use; bacteriological preparations for medical use; balms for medical use; albuminous preparations for medical use in the nature of albumin dietary supplements; biological preparations for medical use, namely, for the treatment of cancer, HIV, and for the regeneration of organs and tissue; bismuth preparations for pharmaceutical use; vitamin preparations; diagnostic preparations for medical use; hemorrhoid treatment preparations; preparations to facilitate teething in the nature of oral analgesics; products for the treatment of burns, namely, burn dressings, burn relief medication, skin grafts for the treatment of burns; sanitary sterilizing preparations; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for skin care; contact lens cleaning preparations; therapeutic medicated bath preparations; medicinal hair growth preparations; preparations of trace elements in the nature of vitamins and mineral supplements for human consumption; sulfonamide preparations; sunburn preparations for pharmaceutical use; enzyme preparations for medical use; pharmaceutical preparations for use in chemotherapy; chemical preparations for medical purposes, namely, for the diagnosis of pregnancy; chilblain preparations; vaginal washes; contact lens solutions; hygienic bandages, namely, bandages for skin wounds, ear bandages, menstruation bandages; suppositories; soporifics; mineral water salts for medical purposes; salts for medical purposes in the nature of medicated bath salts, mineral and sodium salts for medical purposes; anesthetics in the nature of general anesthetics, local anesthetics, topical anesthetics; antiseptics; analgesics; medicines for the treatment of intestinal worms, namely, vermifuges; appetite suppressants for medical use; medical preparations for slimming purposes; febrifuges; depuratives for the body; migraine treatment preparations; remedies for perspiration, namely, prescription medicines for the treatment of excessive perspiration; chemical contraceptives, namely, contraceptive preparations, injectable contraceptives, and contraceptive foams; anti-parasitic preparations; purgatives; nerviness, namely, pharmaceutical preparations for peripheral nervous system, central nervous system stimulants; tranquillizers; digestives for pharmaceutical use; medicinal herbs; enzymes for medical use; ferments for pharmaceutical use; herbal teas for medicinal purposesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 18, 2024DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Feb 18, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Jun 16, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 28, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 6, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 6, 2022INPCINVALIDATION PROCESSED—
May 17, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 17, 2021C71TCANCELLED SECTION 71—
Mar 3, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 15, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 14, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 14, 2015FIMPFINAL DISPOSITION PROCESSED—
Jun 3, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 3, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 19, 2014GPNXNOTIFICATION PROCESSED BY IB—
Dec 16, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 16, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 3, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 26, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 12, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 5, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 14, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 14, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 14, 2014ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 11, 2014GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 11, 2014GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 11, 2014CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 28, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 28, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 21, 2014ALIEASSIGNED TO LIE—
Jul 14, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 14, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 2, 2014RFNTREFUSAL PROCESSED BY IB—
Jan 14, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 14, 2014RFRRREFUSAL PROCESSED BY MPU—
Jan 14, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 13, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 11, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 7, 2014DOCKASSIGNED TO EXAMINER—
Jan 7, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 3, 2014LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jan 2, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance